Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Arsenal Biosciences
Biotech
Arch closes $3B-plus fund to foster biopharma upstarts
On the heels of Bain's $3 billion fund, Arch Venture Partners has closed a VC fund of "more than $3 billion."
Fraiser Kansteiner
Sep 26, 2024 10:24am
ArsenalBio raises $325M, pivots away from former lead asset
Sep 4, 2024 8:00am
New Biogen research chief aims to add biotech hustle to pharma
Oct 10, 2023 10:50am
Biotech's top money raisers: 2022
Apr 11, 2023 9:19am
Genentech pays $70M to access Arsenal's armory of T-cell tools
Sep 27, 2022 9:40am
